Working at Managed Markets Insight & Technology | Glassdoor

Managed Markets Insight & Technology Overview

Yardley, PA
51 to 200 employees
Company - Private
Biotech & Pharmaceuticals
Unknown / Non-Applicable
MMIT brings transparency and guidance to pharmacy and medical benefit information to ensure consistent, informed decision making across the entire healthcare continuum.

Mission: Build the industry's leading data-driven workflow, analytics and software solutions suite while delivering demand-driving, value added, wrap around services.

Company Updates

  • We are proud to introduce our MMIT Spotlight Series with a variety of employee stories in conjunction with the launch of our new Life at MMIT site!

    Check it out here:

    These employee spotlight stories will give you great insight into what a typical day in the life is like for a variety of different team members at MMIT, from Sales, Client Experience, Implementation, Technology, to Market Research. You will also read about what's new and exciting at MMIT, what trends our teams are looking out for, and learn more about what our employees are like outside the office environment.



See AllSee All

Managed Markets Insight & Technology – Why Work For Us?

We are a team of incredibly diverse and talented individuals all working together towards the common purpose of building the industry's leading data-driven workflow, analytics and software solutions suite while delivering demand-driving, value added, wrap around services within the healthcare & pharmaceutical industry.

Check out our employee stories at

Our comprehensive solutions provide a variety of clients with trusted data solutions, training & guidance, and innovative technology to improve decision making across healthcare. We answer our client's complex questions about current coverage, policies and restrictions, and market events and trends by analyzing and identifying their impacts on the current competitive healthcare landscape.

Eric Kennedy

Jan 28, 2019

Eric Kennedy recently celebrated his 13-year anniversary with MMIT, joining the company in 2006. After several years as a formulary data analyst, he became an implementation manager in 2016, helping to develop creative solutions that link client experience and product design with MMIT’s rich data resources. Kennedy and other implementation managers configure MMIT tools and platforms, onboarding new clients to Analytics 3 and FormTrak applications to meet their unique market access needs.

Q: What’s your day-to-day like?

A: I can put it this way — there’s a quote by Arthur Ashe that sets the tone for each day. He said, ‘Start where you are. Use what you have. Do what you can.’ Each day can be different depending on the number of clients I’m working to implement. Each phase of implementation has its own unique challenges and hurdles, so it’s good to have the ability to rely on the processes that have been established. But each client is different. Every brand marketing team has a different message that they want to convey to the marketplace, so it all depends. I’ve been with this company for 13 years and I’ve learned something new every single day. That’s a tribute to our dynamic teams and the culture that’s being built by our leadership.

Q: How long is a typical project?

A: An Analytics 3 and data feed implementation can take anywhere from five to 15 business days, depending on the complexity of the products. If policy and restriction data is involved, we have to build out the class data, so that can take up to 30 business days. FormTrack and Formulary Search projects can take anywhere from 30 to 90 business days. It depends on where a client is at with their market access strategy, and if they have a clear view of how they want to message that strategy.

Q: How do you configure the MMIT tools for new clients?

A: The implementation team is driven by process. Every implementation starts with gathering all the information needed for a successful configuration. First and foremost, we need a list of products. Brand-new clients with a new product typically lean on MMIT for our expertise. We know their anchor drug(s), and we know their competitor landscape. This gives us the ability to provide a standard view of the market basket as we see fit, and they can adjust accordingly.

Analytics 3 and data feeds are the fastest products to implement. It’s a good starting point for clients and their executive teams when they’re looking for ideas of where to contract, understanding their position in the marketplace and how they stack up against their competitors.

Q: What’s a common issue you work through with clients?

A: The biggest thing is to just be flexible to the clients’ needs; you need to know the right process to get them from start to finish. I’m only with them a short period of time, so I think it’s important to set the right expectation and make sure they have a great experience.

Sometimes you have to realign expectations on a contracted solution, and there have been times when I’ve realized in the middle of a project that a client needs a different solution from us than what was initially contracted. It doesn’t happen often, but it does happen sometimes. You need to be able to say, “Hey, maybe this would be a better fit.” Seeing the bigger picture is key to the client’s happiness.

Q: What industry trends should we be looking out for?

A: I always say clients should look at the fringe of the marketplace. That’s typically where the most innovation and creative energy resides, so it’s where the marketplace gravitates to in time. Take for instance the emergence of big data. I feel that as analytics and data evolve, that will take a more dynamic role in understanding a product’s position and impact on the competitive landscape. That’s a very broad view, of course, but it’s an important perspective to keep in mind, because as the markets continue to shift, big data is going to be more and more relevant. As we build out our analytics tools and databases, we’re growing in our ability to stay dynamic and react to the marketplace as it changes. That’s key to our vision, and we’re carrying it out.

Q: What’s your favorite part of your job?

A: I’m a creative person, so even though processes are nice, I use them as a guide to think outside the box. Whenever I get the opportunity to apply things I’ve learned and meet a client’s needs creatively, and sometimes exceed their expectations, that’s probably the most unique and rewarding part of my job.

Q: What do you like to do outside of work?

A: I’m a big sports fan, so I like to be active, whether it’s working out or playing basketball. My wife and I, we love to travel. We’ve been to China, traveled through Asia as well as South Africa — that was the most impactful trip — and of course the Caribbean. You’ve got to love the beach.

by Carina Belles

Edgett Hilimire

June 24, 2019

Edgett Hilimire is a developer at MMIT. He has worked professionally as a developer since he was 15, and joined the company after working on implementing an artificial intelligence (AI) system for an asbestos claims company. He currently works on developing new software that uses artificial intelligence to improve MMIT’s document collection processes.

Q: Tell us a little bit more about your role at MMIT.

A: I work on developing software that plays a critical part in our collections process. We use the Elastic Search database, which is a new technology that we use to house all of our documents after we collect them. The Elastic Search database then feeds documents into MMIT Reach for our clients to access and into our internal PAR (policies and restrictions) “hunting tool” that helps us surface new policy and restrictions changes.

Q: What’s your favorite part of your job?

A: One of the great things about working here is you’re free to use new technology as it pops up and as it is useful. As a team, we are always looking for ways to incorporate new technology to help resolve any business needs. Everyone will branch out into new technology zones and build proof concepts that they share with the group, which anyone can use to resolve any future problems. We’re able to continuously move forward on our usage of new technology because everyone participates in it. It’s all about how we can use new technology to come up with better solutions.

Q: Is there any new technology that clients should keep an eye on?

A: MMIT has been pushing implementing and improving our use of AI. If anyone is interested in using AI, my advice is to start now. It’s a valuable resource if you take the time to fine tune and train it. The biggest part of implementing any AI system is the feedback loop where humans validate the data coming out of the AI and then feed corrections back into the system. Then AI takes the corrections from this feedback loop and will apply it going forward, and in turn it becomes more and more accurate.

The feedback loop is the trickiest part of the AI, because if you’re not feeding back data into the AI, you’re not doing it right. Once the humans have given the computer enough information to do its job, the computer will always be faster.

Q: Can you go into detail about how MMIT uses machine learning and AI in our tools?

A: Right now, we’re focusing our AI on classifying documents. When Elastic Search feeds a new document into the PAR hunting tool, the AI automatically tries to classify the document as a policy, form, etc. We’re working on implementing a screen in the PAR hunting tool where the AI will classify the document, and then the hunting team will have the option to correct the AI if it tags the document incorrectly. The AI will then take those corrections and will apply it on its next round of classifications. The more the PAR team corrects the AI, the more accurate it will become in classifying documents.

We’re also using the AI to automatically check if a document is an updated version of a previous document. The AI will look at the two documents to find differences in wording to determine if the document is an updated version of a previous doc.

Q: What’s been your biggest victory with the company so far?

A: I would say the collections system has been my biggest victory. The AI can go out and collect new documents every day, and store it in the Elastic Search database. Then the documents feed out into our different tools. It was real team effort to get this collections system to work, and it was an immense success.

I’m not ready to call victory on the AI, but I can smell victory. It’s difficult to work with, and has required input from the development team to the PAR hunting team, so again it’s a real team effort. We all have to understand the end goal and be willing to suffer through a lot of difficulties to produce a system that works and works well.

Q: What are some of the challenges of your role?

A: The challenge is the speed at which we move. Sometimes we move too fast and we pump stuff out and there are times when it doesn’t work, but to me this isn’t always a bad thing. We’re able to learn from our mistakes and improve from them. To me, it’s better to fail early then to fail late. Managing the business desire to get things done now and getting things that work properly can be a challenge.

Q: What do you like to do outside of work?

A: I like to sail, and I like to travel. I’ve traveled to all 50 states except for the northwest region. I’ve also been to Canada, Mexico, Scotland, Guatemala and the Philippines, which I really enjoyed visiting. I might go to Portugal this summer, and I think I’m going to visit California to see some of my friends that live out there.

by Amanda Tadrzynski

Carolyn Zele

Oct 10, 2018

Carolyn Zele is a client success advisor at MMIT. After nearly seven years in senior leadership roles at PBM MedImpact Healthcare Systems, Inc. — where she worked with MMIT products — Zele joined MMIT as one of the first client success leads, pioneering the position in 2016. Zele described how she joined the company, how she tailors solutions for clients and the most challenging parts of her role.

Q: How did you start using MMIT tools while at MedImpact?

A: It’s funny, because I was looking at [a product offered by an MMIT competitor] first, and I thought, I don’t want to just buy the first thing I see. I was running the formulary team [at MedImpact] at the time, but I wanted some competitive analysis. So I actually went to the MMIT website, filled out the little contact form and sent it in, and [Chief Product Officer] Greg [Haskins] is the one who contacted me, and it took off from there. I worked with [MMIT tools] for four years on getting Formulary Navigator ready for the PBM space, floating in all of our [MedImpact] formularies, and using the tool to publish websites. I really loved the technology and the teams that I met.

When I decided that I didn’t want to be in a senior leadership position anymore, I reached out to Greg and asked if there could be a fit [for me at MMIT]. I started out implementing payers into Formulary Navigator, and I just felt I wanted to move over to the challenge of pharmaceutical companies — who knew what I was getting into?

Q: What’s a common issue for clients?

A: Let’s say a client hires a new sales team, and there’s 15 people who think they know what MMIT is, but they’ve never used it. All the training that I provide is use case driven — so how is the end user that I’m talking to going to use and interact with our tools? That is a really important distinction, because when you do navigational training, you can train everyone [in the company] the same exact way, but they may not understand how to use it at the end of the training. A lot of the time, we’re very focused on who’s using the tool, and we want to set up meetings, trainings and demos for each [type of employee]. Sometimes we only get 15 minutes in another meeting for training. You can’t teach anybody navigation in Analytics 3 in 15 minutes, but you can show them one use case in 15 minutes.

Q: What’s the best part of your job?

A: I love solving problems. When I have clients who have a question or think there’s something they don’t like in the data, I love digging deep and helping them solve the problem. I couldn’t imagine myself in a different job at this point.

Q: What are the challenges of your role?

A: You have to be a Jack of all trades. You have to know a little bit of everything. We are a lean organization so we don’t have a lot of people you can tap, so I have to be somewhat of an expert. There’s a lot of improvisation and a lot of evaluating. You have to try to figure out what level of detail everyone you’re working with has the stomach to understand and accept. It’s about understanding who you’re talking to all the time, and being really careful about making sure that you’re still within the boundaries of the job. It’s easy to become too embedded in the client so that they depend on you too much.

Q: What’s been your biggest victory with the company so far?

A: I would say my biggest victory was Amgen. When I took Amgen, we only had one product with them at the time — one class. Over the next year, we added additional classes; now we’re getting ready to add 13 more. At one point, I found out that they were still using [a competitor’s] lives data, and they were trying to reconcile coverage and lives between the two of us. So we said to them, if we prove to you that our lives are more accurate and line up the way you need them to line up, will you switch to our lives everywhere? And they said yes, so we took on the project, and we were able to prove at the end of the day that our lives were more accurate. They started using MMIT lives across all of their brands for the pharmacy benefit, and that to me was a signature moment for MMIT.

Q: What do you like to do outside of work?

A: I’m a first time-time grandma. I have two new grandbabies — they’re twins! They’re a month old. My husband and I also travel, hike and collect wine. We won’t do much traveling until the babies are a little older. We want to stay close to home and watch them grow up

Fiza Bari

Apr 22, 2019

Fiza Bari is a senior market research manager at Zitter Insights, a unit of MMIT, leading the Pharmacy and Therapeutics (P&T) Perspectives team. With her team, she recreates a real world experience by allowing pharma clients to be a “fly on the wall” during a live P&T review. Bari, who holds a bachelor’s degree in molecular medicine and a master’s degree in pharmaceutical sciences, also works on custom market research projects, tapping into Zitter’s robust network of panelists for everything from quick pulse surveys (Zitter’s Payer Rapid Response) to large surveys, which help pharma clients tackle market access challenges.

Q: What’s your day to day like?

A: It’s very dependent on project load. It can be a day where I’m working on multiple projects at the same time, or if I’m not working on multiple projects I’ll be working on proposals, or targeting for potential new sales. It really just depends. Right now, we’re gearing up for a June 1 session on Multiple Sclerosis and NASH (Nonalcoholic Steatohepatitis), working with our panel team and getting our committee and specialists recruited. I’m also wrapping up a quantitative payer study that we’re doing for a pharma client.

Q: Can you walk us through some of Zitter’s P&T solutions?

A: When a manufacturer is looking to launch a new product, or if a competitor is launching a product, we recommend clients conduct a P&T Perspectives around six months to a year before the new product launches. What we’re able to do is replicate what happens in the real world at a payer organization, where they meet and review products. We can simulate a health plan, a PBM or an integrated delivery network; it just depends on the situation.

The meeting starts with a clinical pharmacist presenting the disease state overview, and the current products on the simulated plan’s formulary. They will then provide an overview of the products that are being reviewed, including a summary of the clinical trial data. Disease state specialists then provide their opinion on how they would prescribe the product(s) being reviewed. The clinical pharmacist closes the meeting by providing clinical recommendations for the product(s) for formulary review, then a contracting pharmacist presents current utilization of any existing formulary products, and three pricing scenarios, which can include contracting offers if applicable. The committee then votes on each scenario. The manufacturer gets to see how a simulated plan will review its product in a double-blinded manner. This candid feedback can then inform the client’s value proposition and validate pricing assumptions.

Q: What’s exciting about Zitter’s new relationship with MMIT?

A: I think because MMIT has never ventured into custom market research before, we’re really able to provide solutions for those clients whose questions can’t be answered through policy data alone. MMIT was always one of our competitors, especially when it came to policy data. Given the technology expertise that MMIT has, it is going to be exciting to see how we can improve our operational processes, which can help grow the business. Before, we were more of a boutique style market research firm without the advantage of having that technological backbone.

Q: What industry trends should clients be looking out for?

A: I think with managed care, it’s always evolving. One of the bigger trends last year and one thing that we’re tracking is copay accumulator programs. We’re trying to understand the impact of these programs, especially for clients with high-cost specialty products. It’s a big concern for them if their patients can’t afford their medications because of these programs. It has a ripple effect, because it can impact the patient’s adherence. When issues like this come up, it’s not just impacting the manufacturer, it also impacts patients, and it’s important to remember that.

Q: Any buzzworthy indications to watch out for?

A: I think payers are excited about NASH. There are no FDA-approved products in that category, and it affects a lot of people. It’s not a rare disease, and there are four manufacturers coming out with products in the next two years.

It’s going to be really interesting to see how our P&T Perspectives committee reacts to the data and how they review the new products on formulary. We’re not really sure how these products are going to be priced right now, but it will be interesting to watch the committee have that conversation. Just the fact that there’s four products coming out in a category that has no treatments is huge — it’s a lot of competition.

It will also be interesting to see if NASH manufacturers follow the non-specialty pricing trend that we saw in the chronic and episodic migraine category last year. Amgen’s Aimovig came out with non-specialty pricing, so that definitely impressed payers. Historically, specialty products have always come out with high pricing, so they might be setting a trend there where other manufacturers will be under pressure to come out with non-specialty pricing as well.

Q: What is your favorite part of the job?

A: It’s the most challenging part — just keeping afloat with my workload on so many different kinds of projects. It’s why I wanted to join the custom research team, and it’s why I’ve been on the team for four years. Because of our unique position and the fact that we’re working on everything, I’m always learning. I get to apply my scientific background to highlight key clinical benefits of new drugs, and merge that with understanding the financial impact new products have on the marketplace.

Q: What do you like to do outside of work?

A: I have a two-year-old daughter and another one on the way, so I am kept busy! I like to hang out with my daughter and my husband. We’ve had a cold winter, so we’ve been doing a lot indoors. I’m looking forward to summer and getting back outside!

by Carina Belles

Managed Markets Insight & Technology Reviews

Rating TrendsRating Trends
Recommend to a friend
Approve of CEO
Managed Markets Insight & Technology CEO Jeff Steinberg
Jeff Steinberg
31 Ratings
  • Featured Review

    "Account Executive"

    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Current Employee - Account Executive in Philadelphia, PA
    Current Employee - Account Executive in Philadelphia, PA
    Positive Outlook
    Approves of CEO

    I have been working at Managed Markets Insight & Technology full-time (More than a year)


    Nimble, growing company; proactive with change; very fun and energetic; great leadership


    internal processes sometimes slow to change

See All 54 Reviews

Managed Markets Insight & Technology Photos

Managed Markets Insight & Technology photo of: 2019 Asembia Conference
Managed Markets Insight & Technology photo of: 2019 AMCP Conference
Managed Markets Insight & Technology photo of: MMIT's 2019 Winter Gathering
Managed Markets Insight & Technology photo of: MMIT's 2019 Winter Gathering
Managed Markets Insight & Technology photo of: MMIT's 2019 Winter Gathering
Managed Markets Insight & Technology photo of: MMIT Holiday Decorations 2018
See All PhotosSee All

Managed Markets Insight & Technology Interviews



Getting an Interview

Getting an Interview





    Project Manager Interview

    Anonymous Employee in Yardley, PA
    Accepted Offer
    Positive Experience
    Difficult Interview


    I applied through an employee referral. The process took 3 weeks. I interviewed at Managed Markets Insight & Technology (Yardley, PA) in January 2016.


    I was first interviewed over the phone and then brought in for an onsite interview. I was asked to present a project to the leadership team. PowerPoint and MS Project plan. 30 minutes were given for the presentation and followed by a team interview for 30 minutes. After that I met with the COO and CEO for another 30 minutes.

    Interview Questions

    • How would you tell a client bad news? How do you set expectations with a client?   1 Answer
See All 2 Interviews

Managed Markets Insight & Technology Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add Awards

Work at Managed Markets Insight & Technology? Share Your Experiences

Managed Markets Insight & Technology
  • Star
  • Star
  • Star
  • Star
  • Star
Click to Rate